End-of-life decision making in oncology is a complex landscape, encompassing clinical, ethical, cultural, and human dimensions. It occurs at the intersection of medical possibility, ethical complexity, cultural context, and human experience. Regardless of where they reside, patients at the end of life face profound choices regarding comfort, dignity, and the meaning of hope, regardless of whether cure is no longer attainable or treatment is no longer desired. Across Africa, palliative care, in general, has expanded through community-based and integrated models, yet access, including at life's end, remains limited by resource constraints, workforce shortages, and inadequate availability of essential medicines, particularly opioids. These inequities shape what choice means in practice, often constraining patient preferences and reinforcing the need for system-level integration and culturally responsive care. By contrast, medical aid in dying in the United States reflects a growing emphasis on autonomy and control at the patient level, and it generates evolving clinical practices and ongoing ethical debate. Within the end-of-life spectrum, hope persists as a dynamic and measurable construct associated with improved quality of life and potentially survival, while remaining adaptable to changing goals in advanced illness. Nonetheless, the human dimensions of care—including psychological distress, communication, and relational continuity—are frequently underemphasized in advanced cancer and at the end of life. Addressing these gaps is essential for ensuring that patients obtain support that emphasizes meaning, agency, and dignity at the end of life.
